Related Experiment Video
Updated: Oct 2, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Chemopreventive Properties of Tolfenamic Acid: A Mechanistic Review
David Feldman1, Elizabeth Leahy1, Seong-Ho Lee1
1Department of Nutrition and Food Science, College of Agriculture and Natural Resources, University of Maryland, College Park, MD 20742, United States.
Abstract:
Tolfenamic acid is one of the conventional non-steroidal anti-inflammatory drugs (NSAIDs) commonly used for the treatment of inflammation, migraines and pain. There has been a growing body of experimental evidence that tolfenamic acid possesses anti-cancer activity. However, in order to develop a therapeutic strategy using tolfenamic acid for the treatment of cancer, further research is required to highlight reliable cellular and molecular mechanisms of anti-cancer properties. Tolfenamic acid has been shown to alter the expression of several genes that represent cancer hallmarks including apoptosis, growth arrest, angiogenesis and metastasis. Recently, a couple of research groups including ours reported that tolfenamic acid targets multiple oncogenic or tumor suppressive signaling pathways in various types of cancer models. Here, we highlight multiple molecular targets responsible for the anti-cancer mechanism of tolfenamic acid and the benefits of combinational use of this drug with other anti-cancer drugs.
Insights
Tolfenamic acid, a non-steroidal anti-inflammatory drug (NSAID), shows promise as an anti-cancer agent. Research highlights its molecular mechanisms and potential for combination therapy in cancer treatment.
Area of Science:
- Pharmacology
- Oncology
- Molecular Biology
Background:
- Tolfenamic acid is a non-steroidal anti-inflammatory drug (NSAID) traditionally used for inflammation, migraines, and pain.
- Emerging evidence suggests tolfenamic acid exhibits anti-cancer properties, necessitating further investigation into its mechanisms.
Purpose of the Study:
- To elucidate the cellular and molecular mechanisms underlying the anti-cancer activity of tolfenamic acid.
- To explore the potential of tolfenamic acid as a therapeutic agent for cancer treatment.
- To review the benefits of combining tolfenamic acid with other anti-cancer drugs.
Main Methods:
- Analysis of gene expression changes induced by tolfenamic acid, focusing on cancer hallmarks.
- Investigation of tolfenamic acid's impact on multiple oncogenic and tumor-suppressive signaling pathways in various cancer models.
- Literature review and synthesis of existing research on tolfenamic acid's anti-cancer effects.
Main Results:
- Tolfenamic acid alters gene expression related to apoptosis, growth arrest, angiogenesis, and metastasis.
- The drug targets several key signaling pathways implicated in cancer development and progression.
- Experimental data supports the anti-cancer potential of tolfenamic acid across different cancer types.
Conclusions:
- Tolfenamic acid demonstrates multifaceted anti-cancer mechanisms by modulating critical cellular pathways.
- Its ability to target multiple cancer hallmarks makes it a promising candidate for novel cancer therapies.
- Combination therapy with tolfenamic acid and other anti-cancer agents may enhance treatment efficacy.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Therapeutic Drug Monitoring: Affecting Factors
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Bioactivation and Tissue Toxicity